ATE2429T1 - 6-imidazol-1-yl-3-hydrazino-pyridazine, verfahren zu ihrer herstellung und diese enthaltende arzneimittel. - Google Patents

6-imidazol-1-yl-3-hydrazino-pyridazine, verfahren zu ihrer herstellung und diese enthaltende arzneimittel.

Info

Publication number
ATE2429T1
ATE2429T1 AT80104977T AT80104977T ATE2429T1 AT E2429 T1 ATE2429 T1 AT E2429T1 AT 80104977 T AT80104977 T AT 80104977T AT 80104977 T AT80104977 T AT 80104977T AT E2429 T1 ATE2429 T1 AT E2429T1
Authority
AT
Austria
Prior art keywords
hydrazino
preparation
imidazole
pyridazine
medications containing
Prior art date
Application number
AT80104977T
Other languages
German (de)
English (en)
Inventor
Gerd Dr. Steiner
Josef Dr. Gries
Dieter Dr. Lenke
Original Assignee
Basf Aktiengesellschaft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Basf Aktiengesellschaft filed Critical Basf Aktiengesellschaft
Application granted granted Critical
Publication of ATE2429T1 publication Critical patent/ATE2429T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
AT80104977T 1979-09-01 1980-08-21 6-imidazol-1-yl-3-hydrazino-pyridazine, verfahren zu ihrer herstellung und diese enthaltende arzneimittel. ATE2429T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19792935359 DE2935359A1 (de) 1979-09-01 1979-09-01 6-imidazolyl-3-hydrazino-pyridazine
EP80104977A EP0026321B1 (de) 1979-09-01 1980-08-21 6-Imidazol-1-yl-3-hydrazino-pyridazine, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel

Publications (1)

Publication Number Publication Date
ATE2429T1 true ATE2429T1 (de) 1983-03-15

Family

ID=6079798

Family Applications (1)

Application Number Title Priority Date Filing Date
AT80104977T ATE2429T1 (de) 1979-09-01 1980-08-21 6-imidazol-1-yl-3-hydrazino-pyridazine, verfahren zu ihrer herstellung und diese enthaltende arzneimittel.

Country Status (6)

Country Link
US (1) US4399137A (US07816562-20101019-C00012.png)
EP (1) EP0026321B1 (US07816562-20101019-C00012.png)
JP (1) JPS5636483A (US07816562-20101019-C00012.png)
AT (1) ATE2429T1 (US07816562-20101019-C00012.png)
CA (1) CA1155847A (US07816562-20101019-C00012.png)
DE (2) DE2935359A1 (US07816562-20101019-C00012.png)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4521416A (en) * 1983-03-22 1985-06-04 Warner-Lambert Company 4,5-Dihydro-6-[(substituted)-1H-imidazol-4-yl or 5-yl]-3(2H)-pyridazinones and 6-[(substituted)-1H-imidazol-4-yl or 5-yl]-3(2H)-pyridazinones
US5001125A (en) * 1984-03-26 1991-03-19 Janssen Pharmaceutica N.V. Anti-virally active pyridazinamines
US4604127A (en) * 1984-07-17 1986-08-05 Eli Lilly And Company Herbicidal pyridazinylimidazolidinone compounds
US4600430A (en) * 1985-02-22 1986-07-15 Eli Lilly And Company Pyridinylimidazolidinone compounds
DE3922441A1 (de) * 1989-07-07 1991-01-17 Pharmatrans Sanaq Ag Ibuprofen- und s-(+)-ibuprofen-zubereitungen und verfahren zu ihrer herstellung

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3642792A (en) * 1968-02-26 1972-02-15 Lepetit Spa Pyridazine derivatives
DE2516040C2 (de) * 1974-06-10 1984-12-20 Dr. Karl Thomae Gmbh, 7950 Biberach Benzimidazole, Verfahren zu deren Herstellung und diese enthaltende Arzneimittel
US4134983A (en) * 1975-03-03 1979-01-16 Merck & Co., Inc. 3-amino-2-or-propoxyaryl substituted imidazoles
HU175471B (hu) * 1977-06-13 1980-08-28 Gyogyszerkutato Intezet Sposob poluchenija novykh proizvodnykh 3-skobka-1-pirazolil-skobka zakryta-piridazina
HU176100B (en) * 1977-10-25 1980-12-28 Gyogyszerkutato Intezet Process for preparing new 3-/1-pyrazolyl/-pyridazine derivatives

Also Published As

Publication number Publication date
CA1155847A (en) 1983-10-25
US4399137A (en) 1983-08-16
JPS5636483A (en) 1981-04-09
DE2935359A1 (de) 1981-03-26
EP0026321B1 (de) 1983-02-09
DE3061907D1 (en) 1983-03-17
EP0026321A1 (de) 1981-04-08
JPS6334874B2 (US07816562-20101019-C00012.png) 1988-07-12

Similar Documents

Publication Publication Date Title
ATA457772A (de) Verfahren zur herstellung von festen, denwirkstoff langsam abgebenden pharmazeutischen zubereitungen
DE3366141D1 (en) 1-phenylisoquinoline derivatives, process for their preparation, pharmaceutical compositions containing these compounds and their use
ATE25246T1 (de) Triphenylimidazolyloxyalkansaeuren und ihre derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate.
IS3284A7 (is) Aðferð við framleiðslu á N1-súbstitúeruðum bensimidasólafleiðum til að nota við lækningar
DE3575725D1 (de) Neue pyrrolo-benzimidazole, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel.
SE7902742L (sv) Disubstituerade 3-cefem-4-karboxylsyraderivat samt forfarande for framstellning derav
ATE38988T1 (de) Imidazolylphenyl-tetrahydropyridazine, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate.
ATE4707T1 (de) Pyridyl- und imidazopyridyloxypropanolamine, verfahren zu ihrer herstellung und pharmazeutische zusammensetzungen sie enthaltend.
ATE4203T1 (de) 4-aryloxy- und 4-arylthio-3-phenylpiperidinderivate, verfahren zur herstellung solcher verbindungen und diese enthaltende pharmazeutische zusammensetzungen.
ATE66230T1 (de) Neue pyrrolo-benzimidazole, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel.
NO155289C (no) Analogifremgangsmaate for fremstilling av terapeutisk virksomme 4,5-umettede prostansyrederivater.
ATE2429T1 (de) 6-imidazol-1-yl-3-hydrazino-pyridazine, verfahren zu ihrer herstellung und diese enthaltende arzneimittel.
ATE27157T1 (de) Cycloalkylderivate von benzisoselenazolonen, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate.
PT74721B (de) Oxindol-derivate verfahren zu ihrer herstellung und sie enthaltende arzneimittel mit neuroanaboler wirkung
ATE5256T1 (de) Phenylpiperazinderivate von 1,3,4oxadiazolylphenolen, ihre herstellung und diese enthaltende therapeutische mittel.
ATE10841T1 (de) Tricyclische thiazolyloxamidsaeuren und derivate, verfahren zu ihrer herstellung und diese enthaltende therapeutische mittel.
ATE37548T1 (de) Thiazaspiranderivate, verfahren zu ihrer herstellung und arzneimittel.
IE781308L (en) Benzylpyrimidines
ATE1066T1 (de) Aminopropanolderivate des 6-hydroxy-2,3,4,5-tetrahy dro-1h-1-benzazepin-2-ons, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zubereitungen.
DE69017265D1 (de) Pyrrolidonderivate, Verfahren zu ihrer Herstellung und sie enthaltende Arzneimittel.
ATE4808T1 (de) Piperidinderivate von 3-hydroxy-thiophen-2carbons[ureestern,ihre herstellung und diese enthaltende pharmazeutische zubereitungen.
AT342761B (de) Verfahren zur herstellung von homopyrimidazol-derivate enthaltenden, stabilen pharmazeutischen praparaten zur oralen verabreichung
ATE82016T1 (de) 1,4-dihydropyridinderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel.
ATE69809T1 (de) Leukotrienantagonisten, verfahren zu ihrer herstellung, ihre anwendung zur behandlung von krankheiten.
ES508757A0 (es) "procedimiento para la preparacion de acidos antranilicos sustituidos con radicales basicos"

Legal Events

Date Code Title Description
REN Ceased due to non-payment of the annual fee